IR-MED Reports 92% Efficacy for PressureSafe™ in Early, Non-Invasive, Skin Color Agnostic Detection of Pressure Injuries
The objective of the study was to evaluate the sensitivity, specificity, and usability of PressureSafe to detect early-stage pressure injuries Stage 1 / suspected deep tissue injuries (sDTI) before skin breakage, compared to standard of care.
- The objective of the study was to evaluate the sensitivity, specificity, and usability of PressureSafe to detect early-stage pressure injuries Stage 1 / suspected deep tissue injuries (sDTI) before skin breakage, compared to standard of care.
- PressureSafe detected biomarkers and changes in tissue structures under the skin’s surface as they relate to pressure injuries.
- The 14-day efficacy portion of the single arm, bi-center study evaluated 38 patients at high risk of pressure injury development.
- Based on these data, the study concluded that PressureSafe is a safe, efficient, and valuable method for early detection of pressure injuries.